medigraphic.com
ISSN 1684-1824 (Electronic)

2015, Number 1

<< Back Next >>

Rev Méd Electrón 2015; 37 (1)

Adverse reactions in clinical trials carried out in Brazil with new drugs. Years 2000-2012

Garbi NMR, Pastor E, Garbi NA, Guilhem D, Cañete VR

Language: Spanish
References: 11
Page: 18-29
PDF size: 308.48 Kb.


ABSTRACT

Background: clinical trials are an experimental kind design used to assess any diagnostic and therapeutic performance applied to human beings.
Aim: to assess the reports of adverse reactions to drugs, according to causality, seriousness, age and vulnerable groups in protocols of new drugs clinical trials analyzed in the Research Ethic Committee of Brasilia Health Secretariat, Federal District, Brazil.
Method: cross-sectional, descriptive, observational study of case study kind. As universe of work, we took into account the projects assessed by the Research Ethic Committee of Brasilia Health Secretariat, Federal District (CEI/SES/DF in Portuguese) in the period from 2000 to 2012.
Outcomes: 59 % of the research corresponded to national studies and 41 % to international ones. The pharmaceutical industry was the financeable source in 65 % of the cases and there it was foreign participation in 41 % of them. 19 % of the studied drugs were not registered in the National Agency of Sanitary Surveillance (ANVISA in Portuguese) and control group was used in only 9.5 % of the trials. The adverse reactions were considered as related to drugs, possible or improbable in 15.7 %, 19.8 % and 63.6 %, respectively.
Conclusions: most of the research where new drugs were assessed was carried out by Brazilian institutions and most of them received international financial support. The lack of registration of several new products in the national regulatory agency and not using control groups were limitations identified during the assessing process in several clinical trials. We identified the inexistence of unique models legally validated for the evaluation of adverse events to drugs.


REFERENCES

  1. Cohen MG. Latinoamérica en los ensayos clínicos internacionales: ¿Donde está la diferencia? ¿Son los pacientes, los médicos o el sistema? Rev Argent de Cardio. 2003;71(1):6-15. Citado en LILACS; 354454.

  2. Anderson EE, DuBois JM. The need for evidence-based research ethics: A review of the substance abuse literature. Drug and Alcohol Dependence. 2007;86:95-105. Citado en PubMed; PMID:1693085.

  3. Guilhem D, Novaes MRCG. Ética e Pesquisa Social em Saúde. In: Fleischer, Schuch P. Ética e Regulamentação na Pesquisa Antropológica. Brasilia : Letras Livres Ed UnB; 2010 . p.248.

  4. Dal-Ré Saavedra R, Casas A, de los Reyes López M, Gomis R, Avendaño C, Gracia Guillén DM, Moreno González A, et al. Comités éticos de investigación clínica y ‘’dictamen único’’ de los ensayos clínicos multicéntricos. Med Clin [Internet]. 2003 [citado 3 Abr 2011];120(5):180-88. Disponible en http://dialnet.unirioja.es/servlet/articulo?codigo=307523

  5. Moher D, Hopewell, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. Citado en PUBMED; PMID: 20332511.

  6. Garbi Novaes MR, Lolas F, Quezada A. Ética y Farmácia. Una Perspectiva Latinoamericana. Monografias de Acta Bioethica n° 02. Programa de Bioética da OPS/OMS. Washington, D.C: OPS; 2009.

  7. Garbi Novaes MR, Guilhem D, Lolas F. Dez años de Experiencia do Comitê de Ética em Pesquisa da Secretaria de Saúde do Distrito Federal, Brasil. Acta Bioéth [Internet]. 2008 [citado 3 Abr 2011];14(2):185-92. Disponible en: http://www.scielo.cl/scielo.php?pid=S1726- 569X2008000200008&script=sci_arttext&tlng=e

  8. Novaes MRCG, Guilhem D, Lolas F. Ethical Conduct in Research Involving Human Beings In Brazil.Arq Med [internet]. 2009 [citado 3 Abr 2011];23(4):145-50. Disponible en: http://www.scielo.oces.mctes.pt/pdf/am/v23n4/v23n4a02.pdf

  9. Mercosul. Grupo Mercado Comum. Resolução nº 129/96. Boas práticas clínicas [internet]. 1996 [citado 3 Abr 2011]. Disponible en: http://www.ufrgs.br/bioetica/bpcmerco.htm

  10. Ministério da Saúde. Conselho Nacional de Saúde. Sistema nacional de informações sobre ética em pesquisas envolvendo seres humanos–SISNEP. Brasília: CNS/ ;2004 [citado 3 Abr 2011]. Disponible en: http://conselho.saude.gov.br/Web_comissoes/conep/aquivos/sisnep/apresentacao. ppt

  11. Glickman SW, Mchutchison JG, Peterson ED, Cairns ChB, Harrington RA, Califf RM, et al. Ethical and Scientific Implications of the Globalization of Clinical Research. The New England Journal of Medicine [Internet]. 2009 [citado 3 Abr 2011];360(8):816-23.Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMsb0803929




2020     |     www.medigraphic.com